CoChat

A Randomized, Placebo-Controlled Trial of Citicoline Add-On Therapy in Outpatients With Bipolar Disorder and Cocaine Dependence

Brown, E. Sherwood, Gorman, April R., Hynan, Linda S. · 2007 · Journal of Clinical Psychopharmacology

The DOI matches its Crossref record; 21 of the 23 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Bipolar disorder is associated with the highest rates of substance abuse of any psychiatric disorder. Cocaine use is particularly common in patients with bipolar disorder. Both cocaine use and bipolar disorder are associated with mood symptoms and cognitive impairment. Therefore, treatments that stabilize mood, improve cognition, and reduce cocaine use would be useful. Citicoline modulates phospholipids metabolism and neurotransmitter levels and appears to improve cognition in some central nervous system disorders. A 12-week, randomized, placebo-controlled, parallel-group, add-on, proof-of-concept trial of citicoline was conducted in 44 outpatients with a history of mania or hypomania and cocaine dependence. The primary aim was to examine memory, but mood and cocaine use were also assessed. METHOD: Participants were evaluated with a structured diagnostic interview; Inventory of Depressive Symptomatology-Self-Report, Young Mania Rating Scale, and Rey Auditory Verbal Learning Test. Cocaine use was assessed with urine drug screens. Data were analyzed using mixed-model analysis of covariance, generalized estimating equations, and logistic regression analyses that used all of the available data. RESULTS: A significant group effect (P = 0.006) favoring citicoline was observed on the Rey Auditory Verbal Learning Test alternative word list. No significant between-group differences were found on the Inventory of Depressive Symptomatology-Self-Report or Young Mania Rating Scale. The citicoline group had a significantly lower probability of a cocaine-positive urine at exit (P = 0.026). The covariate-adjusted odds ratio estimate was 6.41, suggesting that those who took placebo had 6.41-times higher odds of testing positive for cocaine at exit than those who took citicoline. Citicoline was well tolerated, with no participants to our knowledge discontinuing because of medication side effects. CONCLUSIONS: The use of citicoline was associated with improvement relative to placebo in some aspects of declarative memory and cocaine use, but not mood. The findings are promising and suggest that larger trials of citicoline are warranted.

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0b013e31814db4c4

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Cited by

See all 79

Metadata

Authors
Brown, E. S., Gorman, A. R., & Hynan, L. S.
Affiliations
The University of Texas Southwestern Medical Center (US)
Corresponding author
  • Brown, E. Sherwood
  • Hynan, Linda S.
Venue
Journal of Clinical Psychopharmacology
Published
2007-10
Volume
27
Issue
5
Pages
498-502
ISSN
0271-0749 (ISSN-L)
OpenAlex
W1983429216
Cited by
79
References
23
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 3 · 2017: 7 · 2016: 2 · 2015: 7 · 2014: 7 · 2013: 4 · 2012: 7
FWCI
2.56
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
citicoline, bipolar disorder, cocaine dependence, adjunctive therapy, memory, declarative memory, cocaine use, mood, mania, hypomania, cognitive impairment, outpatients
MeSH terms
Adult, Affect, Bipolar Disorder, Cytidine Diphosphate Choline, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Memory Disorders, Middle Aged, Pilot Projects, Psychiatric Status Rating Scales, Comorbidity, Behavior, Addictive, Treatment Outcome, Diagnosis, Dual (Psychiatry), Nootropic Agents, Cocaine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized, Placebo-Controlled Trial of Citicoline Add-On Therapy in Outpatients With Bipolar Disorder and Cocaine Dependence. https://app.cochat.ai/papers/10.1097/jcp.0b013e31814db4c4
The paper
Brown, E. S., Gorman, A. R., & Hynan, L. S. (2007). A Randomized, Placebo-Controlled Trial of Citicoline Add-On Therapy in Outpatients With Bipolar Disorder and Cocaine Dependence. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0b013e31814db4c4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.